Clinical Roundup Mid-treatment imaging can be used to de-escalate therapy for OPC February 25, 2022Vol.48 No.08
Clinical Roundup TTMV-HPV DNA biomarker test predicts recurrence of HPV-driven oropharynx cancer after treatment February 25, 2022Vol.48 No.08
Clinical Roundup Sylvester, MSK study illuminates resistance to Loxo-305 in CLL February 25, 2022Vol.48 No.08
Clinical Roundup ACS National Consortium publishes recommendations to increase cancer screening rates to pre-pandemic levels February 18, 2022Vol.48 No.07
Clinical Roundup SWOG study: Women at higher risk of severe adverse events from targeted therapy, immunotherapy February 18, 2022Vol.48 No.07
Clinical Roundup Yale, Maryland study: IXA+BEV effective for patients with advanced ovarian cancer February 18, 2022Vol.48 No.07
Clinical Roundup Yale study validates enfortumab vedotin as therapy for aggressive bladder cancer February 18, 2022Vol.48 No.07
Clinical Roundup Interim findings from MIRAGE phase III randomized trial support MRIdian MRI guidance in SBRT for localized prostate cancer February 18, 2022Vol.48 No.07
Clinical Roundup ACS report: Breast cancer now leading cause of cancer death in African American/Black women February 11, 2022Vol.48 No.06
Clinical Roundup AACR report focuses on impact of COVID-19 on cancer research and care February 11, 2022Vol.48 No.06
